Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption
Cancer Cell · 2026-08 · 44 (8) · 1705-1709
DOI: 10.1016/j.ccell.2026.06.014 ↗Kurz gefasst
Korrektur in der Zeitschrift Cancer Cell, 2026-08. Verfasst von Chan Kim und 16 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kim, C., Yang, H., Fukushima, Y., Er Saw, P., Lee, J., Park, J. S., Park, I., Jung, J., Kataoka, H., Lee, D., Heo, W. D., Kim, I., Jon, S., Adams, R. H., Nishikawa, S. I., Uemura, A., & Koh, G. Y. (2026). Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption. Cancer Cell, 44(8), 1705-1709. https://doi.org/10.1016/j.ccell.2026.06.014
Vancouver
Kim C, Yang H, Fukushima Y, Er Saw P, Lee J, Park JS, et al. Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption. Cancer Cell. 2026;44(8):1705-1709. doi:10.1016/j.ccell.2026.06.014
BibTeX
@article{Kim2026,
author = {Kim, Chan and Yang, Hanseul and Fukushima, Yoko and Er Saw, Phei and Lee, Junyeop and Park, Jin-Sung and Park, Intae and Jung, Jinmyung and Kataoka, Hiroshi and Lee, Doheon and Heo, Won Do and Kim, Injune and Jon, Sangyong and Adams, Ralf H and Nishikawa, Shin-Ichi and Uemura, Akiyoshi and Koh, Gou Young},
title = {Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption},
journal = {Cancer Cell},
year = {2026},
volume = {44},
number = {8},
pages = {1705--1709},
doi = {10.1016/j.ccell.2026.06.014}
}
EUVIMED